3 Top Healthcare Stocks to Buy Right Now
These stocks are bargains.
Illumina
ILMN
ILMN
$313.16
$6.69
2.2%
BATS BZX Real Time Price as of May 22, 2019, 3:37 p.m.
View Interactive ILMN Charts
Illumina is a developer, manufacturer and marketer of next-generation life-science tools and integrated systems for the analysis of genetic variation and biological function.
News & Analysis: Illumina
The Fool has written over 400 articles on Illumina.
All
Market Moves
Podcasts
Earnings
3 Healthcare Stocks I'd Buy Right Now
They're leaders in their markets. And those markets should grow tremendously.
3 Stocks to Buy and Hold for Decades
These companies focused on genetics, glamor, and gaming are worth considering for the long haul.
Where Will Illumina Be in 10 Years?
The gene sequencing pioneer could face several scenarios in the future -- from very good to very bad.
5 Top Stocks to Buy in May
Find out why this team of Motley Fool contributors believe these businesses are strong buys right now.
Illumina Inc (ILMN) Q1 2019 Earnings Call Transcript
ILMN earnings call for the period ending March 31, 2019.
Illumina Hits a Lull in the First Quarter
The gene-sequencing leader's revenue and earnings growth rates slowed down in the first quarter, but stronger growth is likely on the way.
Illumina Reports Its Q1 Results on Thursday: 3 Things You Can Expect
The gene-sequencing pioneer isn't likely to hit a home run in Q1. But Illumina should run up the score later in 2019.
Pump the Brakes on the Illumina and Pacific Biosciences Deal
The United Kingdom's Competition and Markets Authority has opened an investigation into the acquisition. What happens now?
Top Gene-Sequencing Stocks for 2019
These next-generation companies are working on game-changing ways to obtain and profit from genetic insight.
